Amy C. Peterson - 16 Mar 2023 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
EVP, Chief Development Officer
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Amy C. Peterson
Issuer symbol
CTMX
Transactions as of
16 Mar 2023
Net transactions value
-$8,425
Form type
4
Filing time
20 Mar 2023, 18:43:26 UTC
Previous filing
21 Jul 2022
Next filing
25 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Sale $8,425 -4,257 -6.8% $1.98 58,433 16 Mar 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units.
F2 Includes 30,000 restricted stock units.